As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are ...

Funding cuts have shaken every state, but the South is acutely vulnerable when it comes to HIV, said Gregorio Millett, MPH, ...

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we ...